I - II or III commercial trials. As a ClinicalResearchAssociate you will be dedicated to one of our global pharmaceutical.... We are currently looking for a ClinicalResearchAssociate based in France (home based). Key responsibilities include: Full...
Diseases, especially in phases I-II-III, is an asset. As a ClinicalResearchAssociate, you will be dedicated to our global... selection, interim, and close-out) in accordance with the clinical monitoring plan. Developing effective relationships...
trials. What you will be doing: As a ClinicalResearchAssociate, you will be dedicated to one of our global...Overview ICON plc is a world-leading healthcare intelligence and clinicalresearch organization. We’re proud...
What you will be doing: As a ClinicalResearchAssociate, you will be dedicated to one of our global pharmaceutical clients (focused...Overview ICON plc is a world-leading healthcare intelligence and clinicalresearch organisation. From molecule...
What you will be doing: As a ClinicalResearchAssociate, you will be dedicated to one of our global pharmaceutical clients (focused...Overview ICON plc is a world-leading healthcare intelligence and clinicalresearch organisation. From molecule...
be accepted in lieu of degree. Good knowledge of, and skill in applying, applicable clinicalresearch regulatory requirements... with contracted scope of work and Good Clinical Practice. Work with sites to adapt, drive, and track subject recruitment plan in line...
knowledge of principles and techniques for clinicalresearch Good English communication Good knowledge of MS Office Suite... clinical projects, producing high quality deliverables to agreed timelines following relevant standard operating procedures...
Nabla: the leading ambient AI assistant that's redefining healthcare delivery. By streamlining clinical documentation, Nabla... development. Our team counts former Facebook AI Research engineers who anticipated the way AI could transform healthcare...
to providing cancer treatments of the future to the world of today. TRIO is looking for a ClinicalResearchAssociate... and knowledgeable team, TRIO is the place for you! Translational Research in Oncology (TRIO) is a global clinicalresearch...
The BBC hears the owner of the luxury store scoped out his victims on the shop floor, assaulted them in London, Paris and St Tropez, and pressured them to keep quiet. Continue Reading »
Sebi initiated action into Axis Capital after publication of a report titled ‘Is Axis Capital an Investment Bank or a Hedge Fund?’ authored by a research analyst. Continue Reading »
Experts rule out a runaway rally, given the steep valuations across large swathes of the market, expecting large caps to outperform broader markets. Continue Reading »
As of 10 a.m. Eastern time, the Dow Jones was up 1.2 per cent, the Nasdaq Composite was 2.2 per cent higher, and the S&P 500 was 1.5 per cent higher Continue Reading »
While foreign investors remain wary due to high valuations, Wood believes India’s domestic fundamentals will help cushion its markets from global volatility. Continue Reading »
The Indian stock market has gained significantly this year, with the Sensex up 15% and Nifty 50 up 17%. Experts recommend quality stocks for long-term gains amid optimism and caution. Top picks include Persistent Systems and HDFC Life. Continue Reading »
Earlier this month, global brokerage firm Goldman Sachs downgraded Indus Towers from a 'Neutral' rating to 'Sell,' lowering the target price to ₹220. Continue Reading »
Centrum Broking has initiated coverage on the wealth management sector, issuing a REDUCE rating for 360 One WAM and Nuvama Wealth. Target prices are ₹1,050 and ₹7,180, respectively, reflecting downsides for both amid a growing market for wealth management in India. Continue Reading »